公司简介

Akero Therapeutics is committed to providing meaningful treatment options for people with serious metabolic diseases like non-alcoholic steatohepatitis (NASH), a disease marked by inflammation in the liver and liver cell damage resulting in fibrosis, cirrhosis, liver failure and death.

产品/服务

融资信息

融资轮次	融资日期	投资方	融资额度
A轮	2018-06	Apple Tree Partners	$65M

关联公司